Cellular components via ROS and Zn²⁺-mediated damage

Cellular components via ROS and Zn²⁺-mediated damage is a descriptive term for a cytotoxic mechanism rather than a specific molecular target like a receptor or enzyme. This process occurs when a drug or agent causes an influx of zinc ions (Zn²⁺) and a concomitant increase in reactive oxygen species (ROS), leading to the non-specific oxidation and degradation of essential cellular macromolecules including DNA, proteins, and lipids (Yasuda & Tsutsui, 2016). This pathway is primarily associated with the action of antimicrobial agents such as zinc pyrithione, which is used topically to treat dandruff and skin infections by overwhelming the oxidative defenses of fungi and bacteria (Reeder et al., 2011). In research settings, this mechanism is also explored for its potential to induce apoptosis in cancer cells through the use of metal ionophores that disrupt mitochondrial function and trigger oxidative stress (Dineley et al., 2003). Because this target encompasses a broad range of cellular structures, it is highly effective at killing cells but lacks the specificity of traditional targeted therapies. Consequently, its therapeutic application is often limited to topical treatments or highly localized delivery to minimize systemic toxicity and off-target effects on healthy tissues. The disruption of metal homeostasis and the resulting oxidative damage represent a multi-pronged attack that makes it difficult for pathogens to develop resistance. Overall, it represents a physiological state of stress induced by specific chemical agents rather than a single druggable protein.

Other names

Zinc-mediated oxidative stressROS-induced cellular damageMetal-ion mediated cytotoxicityZinc-mediated damage to cellular components

Induction of intracellular reactive oxygen species (ROS) and elevation of labile zinc levels, leading to non-specific oxidative damage to proteins, lipids, and nucleic acids (Reeder et al., 2011; Dineley et al., 2003).